§ Funding Round
Promethera Biosciences raised $25.4M Series C venture round, led by Boehringer Ingelheim.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
Boehringer IngelheimLEAD | — | — |
| Organization | — | |
Pall-ATMI LifeSciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Vesalius BiocapitalLEAD | — | — |
| Organization | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$131.7M
Top Valuation
-
Promethera Biosciences raised $25.4M in a Series C round.
The round was announced on 11/25/14.
The round was led by Boehringer Ingelheim, Vesalius Biocapital.
